Related Experiment Videos
Generation of recombinant antibodies
1Recombinant Antibody Research Group, German Cancer Research Center, Heidelberg, Germany.
Molecular Biotechnology
|December 22, 1999
Summary
Recombinant antibody technology advances novel therapeutic and diagnostic agents. This review covers genetically engineered humanized and fully human monoclonal antibodies and their production methods.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Recombinant antibody technology offers new avenues for developing innovative therapeutic and diagnostic tools.
- Monoclonal antibodies are crucial in modern medicine and research.
Purpose of the Study:
- To review recent advancements in the generation of genetically engineered antibodies.
- To discuss methods for producing humanized and fully human monoclonal antibodies.
Main Methods:
- Literature review focusing on recombinant antibody generation.
- Analysis of various expression systems for antibody production.
Main Results:
- Significant progress has been made in creating humanized and fully human monoclonal antibodies.
- Diverse expression systems are available for efficient antibody production.
Conclusions:
- Recombinant antibody technology is a rapidly evolving field with significant potential.
- Further research into antibody engineering and production systems will drive future therapeutic and diagnostic innovations.